Page 10 of 33 · 771 questions tagged coa.
The specifics, since they change the answer: 99.1% · a wide-pore C18 column · mazdutide. I have the document in front of me and I can read the numbers. What I cannot…
This is my second independent submission on material from the same supplier. I have read the obvious sources and they disagree with each other, so I would rather ask…
Numbers first: a GLP-1 receptor agonist · 96.4%. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
The particulars: 95.2% · a wide-pore C18 column · mazdutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
The specifics, since they change the answer: oral semaglutide · three weeks · 4 °C. I am at the decision point and I would rather think it through than improvise. I…
Stated plainly: orforglipron · eight weeks · minus 20 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Setup, so nobody has to ask: an HPLC purity test · orforglipron. I have used one of these for a while and I am considering switching, which requires a reason. What I…
The case in front of me: 95.2% · a C4 column · retatrutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
What I have: cagrilintide · 95.2%. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
Concretely: 97.1% · VendorInvestigate · 98.8%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
Stated plainly: 97.1% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I have: a GLP-1 receptor agonist · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
Stated plainly: QYB · Hubei Jianxiang Bioscience. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
Setup, so nobody has to ask: Homopeptide · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone…
What I have: Homopeptide · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is…
What I have: sampling plan · WXT. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Setup, so nobody has to ask: 99.4% · a C18 column · ecnoglutide. I have read the primary source rather than the summary, which has left me with more questions. I…
This is a United States plan; I appreciate the answer is jurisdiction-specific. The empirical answer seems settled. The explanation does not. If the honest answer is…
The case in front of me: QSC · cagrilintide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
I have kept every message, invoice and document, which I gather is the useful habit. I can find plenty of assertions about this and almost no reasoning, which is…
Concretely: ecnoglutide · twelve weeks · 30 °C. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I…
Concretely: 99.1% · a C4 column · orforglipron. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Setup, so nobody has to ask: FGP · Xi’an Mokemei Biotechnology. Both of these get recommended confidently by different people, which suggests neither is obviously…
Stated plainly: VendorInvestigate · Shanghai Wibson Biotechnology. The figures are clear enough; the question is what they mean and what they do not. I can supply the…